Search

The article presents a case study of two patients with a history of homozygous familial hypercholesterolaemia (HoFH) who were treated with lomitapide and developed liver steatosis and fatty liver.

The article presents a case study of patients who developed necrotising myositis as drug side-effect, after taking simvastatin and atorvastatin drugs as treatment for their individual disease such as hypercholesterolaemia. Information about the patients drug dosage and effects is discussed. Also outlined are the drugs used by patients to threat the drug side-effect of simvastatin and atorvastatin.

The article describes cases of gastrointestinal symptoms, diarrhoea, abdominal discomfort and/or elevation of ALT and AST levels that developed in four patients, 1 man and 3 women, aged 24 to 32 years, during treatment with lomitapide for homozygous familial hypercholesterolaemia.

The article describes the cases of two patients who developed cognitive dysfunction during treatment with simvastatin for hypercholesterolemia.

The article describes the case of a 57-year-old man who developed rhabdomyolysis while being treated with rosuvastatin for hypercholesterolaemia. The man had previously received simvastatin for two years and was hospitalised with a history of muscle pain, fatigue, weakness and dark urine. Rosuvastatin was discontinued after rhabdomyolysis triggered by rosuvastatin was suspected. He started receiving intravenous (IV) fluids and her condition improved.

The article presents the case of a 45-year-old man who developed rhabdomyolysis during concomitant treatment with colchicine for amyloidosis and atorvastatin for hypercholesterolaemia. The medical history of the patient is described. Examinations done on the patient are discussed. Medications given to the patient are discussed.

An abstract of the article "A woman with axillary red-brown plaques," by M. W. D. Brouwer and colleagues is presented.

The article presents a case study of a 48-year-old man and a 69-year-old woman with myasthenia gravis which developed during treatment with atorvastatin for hypercholesterolaemia.

An abstract of the article "Berberine behind the thriller of marked symptomatic bradycardia," by M. Cannillo and colleagues is presented.

The article presents a case study of 73-year-old man diagnosed with dermatitis while administering simvastin for hypercholesterolaemia treatment.

The article presents a case study of a 78-year-old woman who developed myopathy while receiving atorvastatin for hypercholesterolaemia.

The article describes the case of a 50-year-old man who experienced hyaline inclusion myopathy during treatment with simvastatin for hypercholesterolaemia and hypertriglyceridemia. He developed muscle cramps and pain in his arms, neck, thighs and calves. Simvastatin was discontinued and he experienced a lessened muscle pain. His histopathology confirmed that he has hyaline body myopathy.

This article discusses research being done on the use of antidepressants in patients without known cardiovascular risk. It references a study by S. Monte et al., published in the November 2009 issue of the "European Journal of Clinical Pharmacology." The study used patient data from three linked Italian health databases. It showed that antidepressants increase the risk of initiating treatment for hypertension, diabetes and hypercholesterolemia in the patients.

The article describes the case of a 29-year-old woman who developed toxic epidermal necrolysis (TEN) while under allopurinol regimen. After 15 days of receiving allopurinol for hyperuricaemia and hypercholesterolaemia, the patient complained of a two-day history of conjunctival oedema, watery eyes and generalised exanthematous and pruriginous eruption. Physical and laboratory tests showed possible toxicoderma and bilateral filamentary keratitis linked to allopurinol. The drug was withdrawn and she was treated with antibacterials and antifungals.

The article describes the case of a 70-year-old man who developed necrotic skin ulcers and myopathy while under pravastatin treatment regimen for hypercholesterolaemia. Clinical and laboratory examination on the patient revealed telangiectatic blood vessels in the papillary dermis, patchy lymphoplasmocytic infiltrates and necrotic fibres. His regimen was withdrawn and his condition improved.

The article describes the case of a 67-year-old man who developed muscular disorders while being treated with topical bifonazole cream for intertrigo on his toes and simvastatin for hypercholesterolaemia. The patient has admitted that he has been applying the cream twice a day for several months although he was advised to use it for only three weeks. The condition of the patient was resolved when simvastatin and bifonazole were discontinued.

The article describes the case of an 80-year-old woman who developed a psoriasiform drug eruption while receiving pravastatin for hypercholesterolaemia. She experienced erythematous lesions and high fever. Particular focus is given to the results of her laboratory tests and immunohistochemical studies. Her treatment regimen included etretinate, ciclosporin and topical corticosteroids.

The article describes the case of a female adolescent patient who developed mytotoxicity. The patient with an A3243G mutation acquired the said condition on three separate instances while undergoing treatment with three drugs, atorvastatin, lovastatin and niacin. The patient was suffering from hypercholesterolaemia.

The article discusses a case study involving the development of testicular pain after receiving atorvastatin, lovastatin, and simvastatin for hypercholesterolaemia and cardiovascular disease. It references a study by S. A. Linnebur et al published in the January 2007 issue of the journal "Annals of Pharmacology." The patient experienced most pain while driving, sitting, or wearing tight clothes.

Discusses a case report on a 53-year-old man who developed pigmented purpuric dermatosis during treatment with bexafibrate for hyperchlolesterolaemia. Reference to a study by A. Yung et al which appeared in the July 2005 issue of the "Journal of the American Academy of Dermatology"; Medical history of the patient; Concomitant medication of the patient; Description of the patient's skin.

Discusses research being done on a woman who developed autoimmune hepatitis during treatment with rosuvastatin for hypercholesterolemia. Reference to a study by L. M. M. Wolters and colleague, published in the May 2005 issue of the "European Journal of Gastroenterology and Hepatology"; Clinical presentation of the patient; Dosage of rosuvastatin administered to the patient.

Discusses research being done on a man who developed acute pancreatitis during treatment with simvastatin for hypercholesterolaemia. Reference to a study by R. Pezzilli, R. Ceciliato, R. Corinaldesi and B. Barakat, published in the September 2004 issue of the "Digestive and Liver Disease"; Drugs included in his concomitant medications; Adverse drug reactions associated with simvastatin.